Benitec Biopharma Liabilities 2024

Benitec Biopharma Aktienanalyse

What does Benitec Biopharma do?

Benitec Biopharma Inc is a biopharmaceutical company based in the United States that focuses on developing groundbreaking therapies for the treatment of serious diseases. The company was founded in 1995 and is headquartered in Hayward, California. Benitec Biopharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Benitec Biopharma's Liabilities

Benitec Biopharma's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Benitec Biopharma's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Benitec Biopharma's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Benitec Biopharma's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Benitec Biopharma’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Benitec Biopharma stock

What is the level of liabilities of Benitec Biopharma this year?

Benitec Biopharma has a debt balance of 4.26 M USD this year.

What were the liabilities of Benitec Biopharma compared to the previous year?

The liabilities of Benitec Biopharma have increased by 37.86% increased compared to the previous year.

What are the consequences of high debt for investors of Benitec Biopharma?

High liabilities can pose a risk for investors of Benitec Biopharma, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Benitec Biopharma?

Low liabilities mean that Benitec Biopharma has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Benitec Biopharma affect the company?

An increase in liabilities of Benitec Biopharma can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Benitec Biopharma affect the company?

A decrease in the liabilities of Benitec Biopharma can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Benitec Biopharma?

Some factors that can influence the liabilities of Benitec Biopharma include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Benitec Biopharma so important for investors?

The liabilities of Benitec Biopharma are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Benitec Biopharma take to modify the liabilities?

To change its liabilities, Benitec Biopharma can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Benitec Biopharma pay?

Over the past 12 months, Benitec Biopharma paid a dividend of 0.04 USD . This corresponds to a dividend yield of about 0.49 %. For the coming 12 months, Benitec Biopharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Benitec Biopharma?

The current dividend yield of Benitec Biopharma is 0.49 %.

When does Benitec Biopharma pay dividends?

Benitec Biopharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Benitec Biopharma?

Benitec Biopharma paid dividends every year for the past 0 years.

What is the dividend of Benitec Biopharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Benitec Biopharma located?

Benitec Biopharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Benitec Biopharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Benitec Biopharma from 6/8/2018 amounting to 0.003 USD, you needed to have the stock in your portfolio before the ex-date on 6/1/2018.

When did Benitec Biopharma pay the last dividend?

The last dividend was paid out on 6/8/2018.

What was the dividend of Benitec Biopharma in the year 2023?

In the year 2023, Benitec Biopharma distributed 0 USD as dividends.

In which currency does Benitec Biopharma pay out the dividend?

The dividends of Benitec Biopharma are distributed in USD.